The BioFire® FilmArray® Blood Culture Identification Panels

Early identification and treatment of sepsis are essential to combat one of the leading causes of hospital patient deaths.1 With 43 targets, the newly expanded and FDA-cleared BioFire® Blood Culture Identification 2 (BCID2) Panel detects pathogens and antimicrobial resistance genes directly from positive blood cultures.